Immune-mediated Necrotizing Myopathy

• CLINICAL_TRIALS trial_result · 2026-07-24
  Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]

  A Phase 2/3 trial evaluating the efficacy and safety of Efgartigimod PH20 SC in adults with active idiopathic inflammatory myopathy has comp…

• CLINICAL_TRIALS trial_result · 2022-05-16
  Clinical Trial Update: Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy [Phase 2]

  Phase 2 trial of Zilucoplan in immune-mediated necrotizing myopathy was terminated with posted results in 2022.